Sustained release preparation for therapy of coronary stenosis or obstruction
AssigneeMedgel Corporation
InventorsYasuhiko Tabata, Masashi Komeda
Life of this patent
Estimating the term…
Abstract
A pharmaceutical composition for therapy of coronary artery narrowing or blockage, which comprises a sustained release preparation containing an angiogenesis factor or a gene encoding the same and a gelatin hydrogel is disclosed. Examples of the angiogenesis factor which may be used include e.g., bFGF and other FGFs, VEGF, HGF, PDGF, TGF, angiopoietin, HIF, cytokine, chemokine, adrenomeduline and the like.
Claims4
A pharmaceutical composition for therapy of coronary artery narrowing or blockage, which comprises a sustained release preparation containing an angiogenesis factor or a gene encoding the same and a gelatin hydrogel.
A method for treating coronary artery narrowing or blockage comprising administering to a patient a sustained release preparation containing an angiogenesis factor or a gene encoding the same and a gelatin hydrogel.
Dependencies are inferred from the claim text.